Table II.
Basal and postprandial levels at 1 and 12 days after MI development
| Variable | Control (n = 33) | Patients without type 2 diabetes (n = 171) | Patients with first diagnosed type 2 diabetes (n = 29) | |||||
|---|---|---|---|---|---|---|---|---|
| Basal level | Postprandial level | 1st day | 12th day | 1st day | 12th day | |||
| Basal level | Postprandial level | Basal level | Postprandial level | |||||
| Glucose [mmol/l] | 4.40 (3.60; 5.50) | 4.38 (3.40; 5.80) | 6.20 (5.51; 8.10)a | 5.60 (5.01; 6.20)b | 5.80 (4.91; 6.80) | 6.70 (5.81; 8.10)a | 6.00 (4.80; 7.01) | 6.70 (5.81; 8.11)c |
| Insulin [mU/ml] | 12.50 (8.70; 18.50) | 28.12 (4.80; 43.20) | 12.71 (2.51; 19.80) | 12.52 (2.61; 15.23) | 26.72 (2.37; 41.01) | 14.11 (8.61; 21.0) | 15.32 (10.52; 22.50) | 38.55 (4.72; 63.60)a,c,d |
| C-peptide [ng/ml] | 1.20 (0.73; 1.87) | 1.78 (0.73; 1.98) | 1.03 (0.35; 1.79) | 1.01 (0.50; 1.41) | 2.43 (0.81; 3.43) | 1.01 (0.68; 1.46) | 1.75 (0.72; 1.95)b,c | 3.51 (1.06; 6.74)a,d |
a
Compared with the control group (p < 0.05)
b
statistically significant differences in parameters at day 1 and day 12 (p < 0.05)
c
reliable differences between groups at day 1 (p < 0.05)
d
statistically significant differences between groups at day 12 (p < 0.05).